Phase 4
Completed N=53
Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center
Postoperative Pain · Pain, Acute · Anesthesia
Source: ClinicalTrials.gov NCT04387136 ↗
Enrolled (actual)
53
Serious AEs
0.0%
Results posted
Jun 2022
Primary outcomePrimary: Initial Numeric Rating Scale (NRS) Pain Score Upon Arrival — 4; 4 score on a scale
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
The purpose of this study is to determine if a single dose of sublingual sufentanil given 15-30 minutes prior to wake up is efficacious at reducing recovery room time.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Initial Numeric Rating Scale (NRS) Pain Score Upon Arrival |
4; 4 | — |
| SECONDARY Opioid Use in Recovery Room |
7.5; 15.0 | — |
| SECONDARY OBAS Score |
1.0; 3.0 | — |
Eligibility Criteria
Inclusion Criteria
- Adult patients undergoing outpatient ambulatory surgery undergoing general anesthesia for orthopedic surgery
Exclusion Criteria
- non-english speaking patients
- patients who have allergy or intolerance to the study drugs or derivatives
Data sourced from ClinicalTrials.gov (NCT04387136). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.